Literature DB >> 16859462

Upper-pole access for percutaneous nephrolithotomy: comparison of supracostal and infracostal approaches.

B Lojanapiwat1, S Prasopsuk.   

Abstract

BACKGROUND AND
PURPOSE: The advantage of upper-pole access for nephrolithotomy is direct access to most of the intrarenal collecting system and upper ureter. Upper-pole access can be achieved either supracostally and subcostally. Because of the anatomic location of the kidneys, the supracostal approach is associated with a higher rate of pulmonary complications. We compared the efficacy and safety of the supracostal and infracostal upper-pole approaches. PATIENTS AND METHODS: A total 464 patients were treated with percutaneous nephrolithotomy (PCNL) via the upper pole, of which 170 punctures (group I) were performed supracostally and 294 (group II) subcostally. In both groups, PCNL was done by the standard technique with fluoroscopic guidance. The operative time, success rate, hospital stay, and complications in the two groups were compared.
RESULTS: Patients were stone free in 82.2% and 77.1% of the cases in groups I and II, respectively, and had stone fragments <4 mm in 10.7% and 14.7%, respectively. The operative time, success rate, and septic and hemorrhagic complications were not significantly different in the two groups. Hydrothorax was found in 26 patients (15.3%) of group I and 4 (1.4%) of group II. Only 9 patients (5.3%) in group I needed intercostal drainage.
CONCLUSION: Percutaneous nephrolithotomy via the upper pole is effective using both supracostal and infracostal approaches, with acceptable rates of complications. The rate of pulmonary complications is higher with the supracostal approach. If the supracostal approach is indicated, it should be used with caution.

Entities:  

Mesh:

Year:  2006        PMID: 16859462     DOI: 10.1089/end.2006.20.491

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  29 in total

1.  Supracostal access for miniaturized percutaneous nephrolithotomy: comparison of supracostal and infracostal approaches.

Authors:  Faruk Ozgor; Abdulkadir Tepeler; Ismail Basibuyuk; Onur Kucuktopcu; Yunus Kayali; Fatih Yanaral; Murat Binbay
Journal:  Urolithiasis       Date:  2017-03-30       Impact factor: 3.436

Review 2.  Percutaneous nephrolithotomy: technique.

Authors:  Thomas Knoll; Francisco Daels; Janak Desai; Andras Hoznek; Bodo Knudsen; Emanuele Montanari; Cesare Scoffone; Andreas Skolarikos; Keiichi Tozawa
Journal:  World J Urol       Date:  2017-01-25       Impact factor: 4.226

3.  Nephrostolithotomy.

Authors:  Darryl A Zuckerman; Alena Desai
Journal:  Semin Intervent Radiol       Date:  2011-12       Impact factor: 1.513

Review 4.  Complications in percutaneous nephrolithotomy.

Authors:  Iason Kyriazis; Vasilios Panagopoulos; Panagiotis Kallidonis; Mehmet Özsoy; Marinos Vasilas; Evangelos Liatsikos
Journal:  World J Urol       Date:  2014-09-14       Impact factor: 4.226

5.  [Complications in percutaneous lithotomy].

Authors:  M Ritter; M-C Rassweiler; M S Michel
Journal:  Urologe A       Date:  2014-07       Impact factor: 0.639

6.  RE: Percutaneous nephrolithotomy for isolated calyceal stones: How important is the stone location?

Authors:  Mohd Nazli Kamarulzaman
Journal:  Turk J Urol       Date:  2016-06

Review 7.  Percutaneous nephrolithotomy: complications and how to deal with them.

Authors:  Daniel A Wollin; Glenn M Preminger
Journal:  Urolithiasis       Date:  2017-11-17       Impact factor: 3.436

Review 8.  Research progress of percutaneous nephrolithotomy.

Authors:  Chao Wei; Yucong Zhang; Gaurab Pokhrel; Xiaming Liu; Jiahua Gan; Xiao Yu; Zhangqun Ye; Shaogang Wang
Journal:  Int Urol Nephrol       Date:  2018-03-19       Impact factor: 2.370

9.  Perioperative Respiratory Compromise in Patients Undergoing PCNL-A Case Series.

Authors:  Ponnambala Namasivayam S
Journal:  J Clin Diagn Res       Date:  2013-10-05

10.  Supracostal access for percutaneous nephrolithotomy: less morbid, more effective.

Authors:  Sudhir Sukumar; Balagopal Nair; Kumar P Ginil; K V Sanjeevan; Bhat H Sanjay
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.